compounded semaglutide versus tirzepatide vs Tirzepatide: Dosing, Results, Side Effects, and Who They Fit Tirzepatide vs. semaglutide for weight

Obesity is widely recognised as a chronic, relapsing condition, so it is not unexpected that stopping pharmacotherapy is followed by partial weight regain in many individuals

CrossRefDirect Link Jordao, Jr., A.A., P.G

Important Note This content is intended for educational and research purposes only and does not constitute medical advice, diagnosis, or treatment

In October 2023, the Journal of the American Medical Association examined adverse events associated with GLP-1 receptor agonists prescribed for weight loss, and researchers concluded that using the drugs increases the risk of gastrointestinal adverse effects, such as biliary disease, pancreatitis, bowel obstruction, and stomach paralysis